US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern

US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern

The Age

Published

The announcement comes one day after Johnson & Johnson said it was forced to pause a large high-profile trial of its experimental coronavirus vaccine because a volunteer fell ill.

Full Article